Blood levels of d-amino acids reflect the clinical course of COVID-19

Fajnzylber, 2020, SARS-CoV-2 viral load is associated with increased disease severity and mortality, Nat. Commun., 11, 5493, 10.1038/s41467-020-19057-5

Hagman, 2021, Severe acute respiratory syndrome coronavirus 2 RNA in serum as predictor of severe outcome in coronavirus disease 2019: a retrospective cohort study, Clin. Infect. Dis. : an official publication of the Infectious Diseases Society of America, 73, e2995, 10.1093/cid/ciaa1285

Jacobs, 2022, Severe acute respiratory syndrome coronavirus 2 viremia is associated with coronavirus disease 2019 severity and predicts clinical outcomes, Clin. Infect. Dis. : an official publication of the Infectious Diseases Society of America, 74, 1525, 10.1093/cid/ciab686

Li, 2021, SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes, J. Clin. Invest., 131, 10.1172/JCI148635

Zoufaly, 2020, Human recombinant soluble ACE2 in severe COVID-19, Lancet Respir. Med., 8, 1154, 10.1016/S2213-2600(20)30418-5

Weinreich, 2021, REGEN-COV antibody combination and outcomes in outpatients with Covid-19, N. Engl. J. Med., 385, e81, 10.1056/NEJMoa2108163

Isaka, 2023, Establishment and clinical application of SARS-CoV-2 catch column, Clin. Exp. Nephrol ., 27, 279, 10.1007/s10157-022-02296-9

Hamase, 2002, D-Amino acids in mammals and their diagnostic value, J. Chromatogr., B: Anal. Technol. Biomed. Life Sci., 781, 73, 10.1016/S1570-0232(02)00690-6

Kimura, 2016, Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease, Sci. Rep., 6, 10.1038/srep26137

Hesaka, 2019, D-Serine reflects kidney function and diseases, Sci. Rep., 9, 5104, 10.1038/s41598-019-41608-0

Kawamura, 2022, Measurement of glomerular filtration rate using endogenous d-serine clearance in living kidney transplant donors and recipients, EClinicalMedicine, 43, 10.1016/j.eclinm.2021.101223

Kimura, 2020, d-Amino acids and kidney diseases, Clin. Exp. Nephrol., 24, 404, 10.1007/s10157-020-01862-3

Kimura-Ohba, 2022, d-Alanine as a biomarker and a therapeutic option for severe influenza virus infection and COVID-19, Biochim. Biophys. Acta, Mol. Basis Dis., 1869, 10.1016/j.bbadis.2022.166584

Hamase, 2018, Determination of trace amounts of chiral amino acids in complicated biological samples using two-dimensional high-performance liquid chromatography with an innovative “shape-fitting” peak identification/quantification method, Chromatography, 39, 147, 10.15583/jpchrom.2018.019

Sasabe, 2016, Interplay between microbial d-amino acids and host d-amino acid oxidase modifies murine mucosal defence and gut microbiota, Nature Microbiology, 1, 10.1038/nmicrobiol.2016.125

Nagata, 1987, Free D-amino acids in human plasma in relation to senescence and renal diseases, Clin. Sci. (Lond.), 73, 105, 10.1042/cs0730105

Morikawa, 2008, Circadian changes of D-alanine and related compounds in rats and the effect of restricted feeding on their amounts, J. Chromatogr., B: Anal. Technol. Biomed. Life Sci., 875, 168, 10.1016/j.jchromb.2008.04.004

Suzuki, 2022, Chiral resolution of plasma amino acids reveals enantiomer-selective associations with organ functions, Amino Acids, 54, 421, 10.1007/s00726-022-03140-w